Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights.
Annals of the rheumatic diseases
View this publicationAnnals of the rheumatic diseases
View this publicationDie Ophthalmologie
View this publicationMicrobial cell factories
View this publicationDie Anaesthesiologie
View this publicationRMD open
View this publicationUrologie (Heidelberg, Germany)
View this publicationNature communications
View this publicationJournal of clinical medicine
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationThe Lancet. Microbe
View this publication